Systematic Method Development of UPC2 Conditions Using Opioid Drugs

Importance of the Topic

The accurate and rapid analysis of natural semi synthetic and synthetic opioids is crucial in clinical forensic and quality control laboratories. Conventional liquid and gas chromatography methods often struggle with selectivity throughput and solvent compatibility for polar basic compounds. UltraPerformance Convergence Chromatography (UPC2) leverages supercritical CO2 and varied stationary phases to deliver orthogonal rapid green separations for challenging opioid analytes.

Objectives and Study Overview

This work presents a systematic UPC2 method development approach applied to 19 opioid drugs. The goal was to identify optimal mobile phase additives column chemistries and sample solvents to achieve baseline separation in under two minutes while maintaining mass spectrometric compatibility.

Methodology

A four column screening protocol evaluated BEH BEH 2-EP CSH Fluoro-Phenyl and HSS C18 SB phases with four methanol based mobile phase B additives: none 0.2% formic acid 0.2% ammonium hydroxide and 0.2% formic acid plus 20 mM ammonium formate. Initial gradients spanned 5–75% MPB at flow rates set to keep system pressure below 6000 psi. Performance metrics included retention peak shape and MS signal. Final optimization involved increasing modifier concentrations sample diluent testing and selection of the best performing column phase.

Instrumentation

• ACQUITY UPC2 System
• ACQUITY UPC2 Columns BEH 2.1×50 mm 1.7 µm and CSH Fluoro-Phenyl 2.1×50 mm 1.7 µm
• ACQUITY TQD Mass Spectrometer positive ESI MRM mode
• MassLynx Software

Main Results and Discussion

A buffered methanol mobile phase containing formic acid and ammonium formate delivered superior retention peak shape and sensitivity across all columns. BEH and CSH Fluoro-Phenyl phases achieved complete baseline separation of 19 analytes in under two minutes. Higher modifier levels (0.4% formic acid 40 mM ammonium formate) reduced peak broadening for oxycodone and oxymorphone. Early eluting compounds like propoxyphene and buprenorphine showed optimal performance on the BEH phase. Sample diluents of isopropanol and acetonitrile/methanol were fully compatible whereas pure methanol caused peak distortions for some early eluters.

Benefits and Practical Applications

• High throughput screening for clinical forensic and QA/QC labs
• Reduced organic solvent use with green CO2 mobile phase
• Orthogonal selectivity complementing UPLC and GC workflows
• Direct compatibility with common bioanalytical sample solvents

Future Trends and Opportunities

The systematic UPC2 method development strategy can be extended to other basic polar pharmaceutical and environmental analytes. Integration with high resolution MS and advanced data analytics will enhance screening in complex matrices. Ongoing stationary phase innovations and novel supercritical fluid modifiers are expected to broaden UPC2 utility in metabolomics lipidomics and environmental testing.

Conclusion

A targeted column and modifier screening approach enabled the development of a rapid sensitive and green UPC2 method for a comprehensive opioid panel. Complete separation in under two minutes with direct MS compatibility highlights UPC2 as a powerful addition to modern analytical laboratories.

References

1. Janicot J Caude M Separation of opium alkaloids by carbon dioxide sub and supercritical fluid chromatography with packed columns Application to quantitative analysis of poppy straw extracts Journal of Chromatography 1988 437 351 364
2. Grand Guillaume Perrenoud A Boccard J Analysis of basic compounds by supercritical fluid chromatography Attempts to improve peak shape and maintain MS compatibility Journal of Chromatography A 2012 1262 205 213
3. ChemAxon Chemicalize org Retrieved Dec 15 2012
4. Lesellier E Retention mechanisms in super subcritical fluid chromatography on packed columns Journal of Chromatography A 2009 1216 1881 1890